World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 44 4800 4441 40 38 144 6673

Fabio T. M. Costa publications per year

The chart shows the history of publications by Fabio T. M. Costa between 1986 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Fabio T. M. Costa published across 40 years, from 1986 to 2025, averaging 5.1 papers a year. Output peaked at 29 publications in 2021. 16 of the 203 publications appeared in the last two years.

No. of publications
5 10 15 20 25
Bar chart. Horizontal axis: year, 1986 to 2025. Vertical axis: number of publications, 0 to 29. Peak 29 publications in 2021. 1986: 1 publication 1987: 0 publications 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 0 publications 1995: 0 publications 1996: 0 publications 1997: 0 publications 1998: 2 publications 1999: 5 publications 2000: 0 publications 2001: 1 publication 2002: 2 publications 2003: 3 publications 2004: 2 publications 2005: 0 publications 2006: 2 publications 2007: 2 publications 2008: 8 publications 2009: 5 publications 2010: 7 publications 2011: 8 publications 2012: 4 publications 2013: 12 publications 2014: 10 publications 2015: 9 publications 2016: 6 publications 2017: 6 publications 2018: 16 publications 2019: 11 publications 2020: 19 publications 2021: 29 publications 2022: 3 publications 2023: 14 publications 2024: 11 publications 2025: 5 publications
1986 2025

203 publications in total across all disciplines

View publications per year as a table
Fabio T. M. Costa: publications per year, 1986 to 2025
Year Publications
1986 1
1987 0
1988 0
1989 0
1990 0
1991 0
1992 0
1993 0
1994 0
1995 0
1996 0
1997 0
1998 2
1999 5
2000 0
2001 1
2002 2
2003 3
2004 2
2005 0
2006 2
2007 2
2008 8
2009 5
2010 7
2011 8
2012 4
2013 12
2014 10
2015 9
2016 6
2017 6
2018 16
2019 11
2020 19
2021 29
2022 3
2023 14
2024 11
2025 5
Total 203
Download as CSV

Fabio T. M. Costa publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Fabio T. M. Costa sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 142–151 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 144 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159 144
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Fabio T. M. Costa D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Fabio T. M. Costa sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 44–45 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157 44
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Fabio T. M. Costa is affiliated with the State University of Campinas in Brazil, focusing on research predominantly within the field of Medicine. Their work spans several subfields, including Public Health, Environmental and Occupational Health, Infectious Diseases, Molecular Biology, Immunology, and Computational Theory and Mathematics.

The scientist has contributed extensively to topics such as Malaria Research and Control, Mosquito-borne Diseases and Control, Computational Drug Discovery Methods, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, and vaccines and immunoinformatics approaches.

Recent publications associated with their research efforts include the following:

  • Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial (2020), Clinical Infectious Diseases
  • A prenylated dsRNA sensor protects against severe COVID-19 (2021), Science
  • Covid-19 Automated Diagnosis and Risk Assessment through Metabolomics and Machine Learning (2021), Analytical Chemistry
  • Keras R-CNN: library for cell detection in biological images using deep neural networks (2020), BMC Bioinformatics
  • Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii (2021), Journal of Controlled Release

Frequent co-authors in their research include:

  • Marcus Lacerda
  • Carolina Horta Andrade
  • Stefanie Costa Pinto Lopes
  • Wuelton Marcelo Monteiro
  • João Luiz Silva-Filho

The scientist often publishes in several recurrent venues, such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • ACS Omega
  • Scientific Reports
  • UNC Libraries
  • Memórias do Instituto Oswaldo Cruz

Best Publications

  • Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial.

    Christiane Maria Prado Jeronimo;Maria Eduarda Leão Farias;Fernando Fonseca Almeida Val;Vanderson Souza Sampaio

  • On the Cytoadhesion of Plasmodium vivax–Infected Erythrocytes

    Bruna O. Carvalho;Stefanie C. P. Lopes;Paulo A. Nogueira;Patricia P. Orlandi

  • Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment

    Elodie Belnoue;Fabio T. M. Costa;Fabio T. M. Costa;Tobias Frankenberg;Ana Margarida Vigário

  • Chloroquine: Modes of action of an undervalued drug

    Rodolfo Thomé;Stefanie Costa Pinto Lopes;Fabio Trindade Maranhão Costa;Liana Verinaud

  • A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax

    Bruce Russell;Rossarin Suwanarusk;Céline Borlon;Fabio T. M. Costa

  • Significant Biochemical, Biophysical and Metabolic Diversity in Circulating Human Cord Blood Reticulocytes

    Benoît Malleret;Fenggao Xu;Narla Mohandas;Rossarin Suwanarusk

  • New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin

    Daniel Y. Bargieri;Daniela S. Rosa;Catarina J.M. Braga;Bruna O. Carvalho

  • Violacein Extracted from Chromobacterium violaceum Inhibits Plasmodium Growth In Vitro and In Vivo

    Stefanie C. P. Lopes;Yara C. Blanco;Giselle Z. Justo;Paulo A. Nogueira

  • Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice

    Fabio Costa;Giovanni Franchin;Vera Lucia Pereira-Chioccola;Marcelo Ribeirão

  • Cytotoxic activity of violacein in human colon cancer cells.

    Daniela D. de Carvalho;Fabio T.M. Costa;Nelson Duran;Marcela Haun

  • Thrombocytopenia in Plasmodium vivax Malaria Is Related to Platelets Phagocytosis

    Helena Cristina C. Coelho;Stefanie C. P. Lopes;João Paulo D. Pimentel;Paulo A. Nogueira

  • Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage.

    Elodie Belnoue;Elodie Belnoue;Tatiana Voza;Tatiana Voza;Fabio T. M. Costa;Fabio T. M. Costa;Fabio T. M. Costa;Anne Charlotte Grüner;Anne Charlotte Grüner;Anne Charlotte Grüner

  • Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene.

    Mauricio M. Rodrigues;Marcelo Ribeirão;Vera Pereira-Chioccola;Laurent Renia

  • Specific Biomarkers Associated With Neurological Complications and Congenital Central Nervous System Abnormalities From Zika Virus-Infected Patients in Brazil.

    Yiu-Wing Kam;Juliana Almeida Leite;Fok-Moon Lum;Jeslin J L Tan

  • Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea

    Camila Bononi Almeida;Camila Bononi Almeida;Lucas Eduardo Botelho Souza;Flavia Costa Leonardo;Fabio Trindade Maranhão Costa

  • Sequestration of Plasmodium falciparum–infected erythrocytes to chondroitin sulfate A, a receptor for maternal malaria: monoclonal antibodies against the native parasite ligand reveal pan-reactive epitopes in placental isolates

    Jean-Bernard Lekana Douki;Boubacar Traore;Fabio T M Costa;Thierry Fusaï

  • Plasmodium falciparum rhoptry protein RSP2 triggers destruction of the erythroid lineage

    Corinne Layez;Paulo Nogueira;Valery Combes;Fabio T. M. Costa

  • Stage-specific transcription of distinct repertoires of a multigene family during Plasmodium life cycle.

    P. R. Preiser;S. Khan;F. T. M. Costa;W. Jarra

  • Human ex vivo studies on asexual Plasmodium vivax: the best way forward.

    Bruce Russell;Rossarin Suwanarusk;Benoit Malleret;Fabio T.M. Costa

  • Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein

    Vera Lúcia Pereira-Chioccola;Fabio Costa;Marcelo Ribeirão;Irene S. Soares;Irene S. Soares

  • Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms

    Ana C Puhl;Ethan J Fritch;Thomas R Lane;Longping V Tse

  • Sequestration of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A, a receptor for maternal malaria: monoclonal antibodies against the native parasite ligand reveal pan-reactive epitopes in placental isolates Running head: Pan-reactive anti-PfEMP1var monoclonal antibodies

    Jurg Gysin;Jean Bernard Lekana Douki;Boubacar Traore;Fabio T Costa

Frequent Co-Authors

Laurent Rénia
Laurent Rénia Nanyang Technological University
Bruce Russell
Bruce Russell University of Otago
Mauricio M. Rodrigues
Mauricio M. Rodrigues Federal University of Sao Paulo
François Nosten
François Nosten MORU Mahidol Oxford Tropical Medicine Research Unit
Nelson Durán
Nelson Durán State University of Campinas
Benoit Malleret
Benoit Malleret National University of Singapore
Octavio L. Franco
Octavio L. Franco Universidade Católica de Brasília
Julio Aliberti
Julio Aliberti National Institute of Allergy and Infectious Diseases
Matthias Marti
Matthias Marti University of Glasgow
Lisa F. P. Ng
Lisa F. P. Ng Agency for Science, Technology and Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their immunology expertise, pursuing nursing degrees can be a complementary path, especially in clinical and research settings. Many students leverage accelerated nurse practitioner programs that allow quicker entry into advanced practice roles, integrating immunological knowledge with patient care.

If you are new to healthcare, there are accessible options such as online ADN programs for non nurses that provide a foundation in nursing without prior experience. These programs prepare students for roles that often intersect with immunological treatments and patient monitoring.

For those seeking a faster entry point into nursing while maintaining a focus on immunology-relevant skills, easiest accelerated nursing programs to get into offer a streamlined pathway to a Bachelor of Science in Nursing. This degree enhances understanding of immune responses and healthcare practices.

Additionally, practical nursing roles can be accessed via easy LPN programs to get into, which provide essential clinical skills that support immunology-related patient care. This path is ideal for those looking for quicker certification and hands-on experience.

Best Scientists Citing Fabio T. M. Costa

Trending Scientists

Recently Published Articles